Phase I study of the combination of oxaliplatin, irinotecan and continuous infusion 5-fluorouracil in digestive tumors-Reference-Cited by-同舟云学术

Phase I study of the combination of oxaliplatin, irinotecan and continuous infusion 5-fluorouracil in digestive tumors

Published:2004-06 Issue:5 Volume:15 Page:469-471
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Abad Albert,Massutí Bartomeu,Gallego Javier,Yuste Ana L.,Manzano José Luis,Carrato Alfredo,Antón Antonio,Marfa Xavier,Diaz-Rubio Eduardo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference11 articles.

1. Phase III multicentre randomized trial of oxaliplatin added to chronomodulated fluorouracil–leucovorin as first line treatment of metastatic colorectal cancer;Giachetti;J Clin Oncol,2000

2. A randomized trial of leucovorin and 5-fluorouracil with or without oxaliplatin in advanced colorectal cancer;De Gramont;J Clin Oncol,2000

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillart;Lancet,2000

4. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer;Saltz;N Eng J Med,2000

5. Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial;Souglakos;J Clin Oncol,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Biocatalytic Synthesis, Pharmacological Activities, Pharmaceutical Preparation and Metabolism of Ginsenoside Rh2;Mini-Reviews in Medicinal Chemistry;2022-02

2. Reversal effect of ginsenoside Rh2 on oxaliplatin‑resistant colon cancer cells and its mechanism;Experimental and Therapeutic Medicine;2019-05-23

3. Silencing the wild-type and mutant K-ras increases the resistance to 5-flurouracil in HCT-116 as a colorectal cancer cell line;Anti-Cancer Drugs;2015-02

4. Triplet schedule of weekly 5-Fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: A dose-finding and phase II study;Oncology Reports;2010-04-23

5. Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer;Therapeutic Advances in Medical Oncology;2010-03-26